Get it on Google Play

Idera Phama (IDP) Discloses Two Positive Presentations of its TLR9 Agonists

April 18, 2007 9:35 AM EDT Send to a Friend
Idera Pharmaceuticals, Inc. (AMEX: IDP) announced two presentations of data for two new potential applications in oncology of its novel ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login